Tailored Borneol-Modified Lipid Nanoparticles Nasal Spray for Enhanced Nose-to-Brain Delivery to Central Nervous System Diseases-Reference-Cited by-同舟云学术

Tailored Borneol-Modified Lipid Nanoparticles Nasal Spray for Enhanced Nose-to-Brain Delivery to Central Nervous System Diseases

Published:2024-08-19 Issue:34 Volume:18 Page:23684-23701
ISSN:1936-0851
Container-title:ACS Nano
language:en
Short-container-title:ACS Nano

Author:

Wang Guanlin¹,Zhai Zizhao²,Wang Wenhao¹,Xia Xiao²,Guo Haihua³,Yue Xiao²,Wang Xiaoyuan¹,Zhu Bing⁴,Huang Zhengwei²⁵^ORCID,Pan Xin¹^ORCID,Huang Ying²⁵^ORCID,Wu Chuanbin¹²⁵,Zhang Xuejuan²⁵

Affiliation:

1. School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, Guangdong, P. R. China

2. College of Pharmacy, Jinan University, Guangzhou 510006, Guangdong, P. R. China

3. Guangdong Province Key Laboratory of Utilization and Protection for Resource of Food and Medicinal Plant in North Region, Shaoguan University, Shaoguan 512005, Guangdong, P. R. China

4. Respirent Pharmaceuticals, Co., Ltd., Chongqing 400714, P. R. China

5. Institute of Advanced Drug Delivery Systems, Jinan University, Guangzhou 510006, Guangdong, P. R. China

Funder

National Natural Science Foundation of China

Natural Science Foundation of Guangdong Province

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acsnano.4c08279

Reference42 articles.

1. Implications of sex-related differences in central nervous system disorders for drug research and development

2. Global, regional, and national burden of brain and other CNS cancer, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

3. Alzheimer's disease

4. The Blood-Brain Barrier/Neurovascular Unit in Health and Disease

5. An overview of in vitro 3D models of the blood-brain barrier as a tool to predict the in vivo permeability of nanomedicines